Takeda Pharmaceutical Company Limited v. Zydus Pharmaceuticals (Usa) Inc.

U.S. Court of Appeals for the Federal Circuit

Takeda Pharmaceutical Company Limited v. Zydus Pharmaceuticals (Usa) Inc.

Opinion

Case: 22-2124 Document: 52 Page: 1 Filed: 10/11/2023

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________

TAKEDA PHARMACEUTICAL COMPANY LIMITED, TAKEDA PHARMACEUTICALS U.S.A., INC., TAKEDA PHARMACEUTICALS AMERICA, INC., Plaintiffs-Appellees

v.

ZYDUS PHARMACEUTICALS (USA) INC., CADILA HEALTHCARE LTD., Defendants-Appellants ______________________

2022-2124 ______________________

Appeal from the United States District Court for the District of New Jersey in No. 3:18-cv-11792-FLW-TJB, Judge Freda L. Wolfson. ______________________

JUDGMENT ______________________

ERIC J. LOBENFELD, Cherry Hill, NJ, argued for plain- tiffs-appellees. Also represented by BENJAMIN HOLT, RYAN STEPHENSON, Hogan Lovells US LLP, Washington, DC.

STEVEN J. MOORE, Withers Bergman LLP, Greenwich, Case: 22-2124 Document: 52 Page: 2 Filed: 10/11/2023

CT, argued for defendants-appellants. Also represented by JAMES EDWARD NEALON, Nealon Law LLC, Stamford, CT. ______________________

THIS CAUSE having been heard and considered, it is

ORDERED and ADJUDGED:

PER CURIAM (MOORE, Chief Judge, STOLL and CUNNINGHAM, Circuit Judges). AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

October 11, 2023 Date

Reference

Status
Unpublished